Trading window closed from June 16 ahead of Q1 FY27 results
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
AstraZeneca Pharma India has closed its trading window from June 16, 2026, in line with SEBI's Insider Trading Regulations and the company's Code of Conduct. The window will reopen 48 hours after the company declares its unaudited financial results for the quarter ending June 30, 2026 (Q1 FY27). Insiders, including directors, officers, and employees, are barred from trading in the company's shares during this blackout period. The intimation was signed by Tanya Sanish, Company Secretary & Compliance Officer.
Routine compliance event. Insiders cannot trade shares until Q1 FY27 results are announced and 48 hours pass post-declaration.